Vancouver, British Columbia–(Newsfile Corp. – November 19, 2025) – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) (the “Company” or “SureNano”) is pleased to announce it has entered into a non-binding letter of intent (the “ LOI “) with GlucaPharm Inc. (“ GlucaPharm “), to conduct legal, technical and financial due diligence on GlucaPharm and its license to the intellectual property as described below (the “ Proposed Transaction “). If the Company elects to proceed following the conclusion of its due diligence, the parties shall negotiate and enter into a definitive binding agreement (the “ Definitive Agreement “). The LOI contains both binding and non-binding terms, the former including mutual confidentiality and due diligence access rights, each party bears own expenses and m

See Full Page